Bausch + Lomb Launches Orphia to Advance AI-Driven Digital Eye Care

In July 2026, Bausch+Lomb launched Orphia, a digital health platform driven by artificial intelligence that was created to enhance patient involvement and streamline clinical procedures in eye care facilities. The platform is intended to lessen administrative burdens so that clinical teams and ophthalmologists can spend more time caring for patients. The startup hopes to improve patient and healthcare provider experiences by incorporating AI into standard healthcare procedures.

Orphia first concentrates on helping people get ready for cataract surgery by offering interactive educational advice prior to consultations through AI-assisted chats. The platform helps patients better comprehend their diagnosis, available treatments, and the surgical procedures. This allows doctors to concentrate more on individualized clinical talks rather than spending extra time discussing routine facts while also empowering patients to join meetings with more knowledge and confidence.

Instead of talking about the place of current clinical workflows, the digital platform is made to seamlessly integrate with them. It helps healthcare providers enhance coordination across all stages of treatment by combining patient education, communication, and practice management skills into an intelligent automation to help clinical teams handle tedious administrative tasks while keeping effective lines of communication open with patients during their course of treatment.

The platforms' usage of sophisticated conversational artificial intelligence to facilitate patient interactions in a natural and approachable way is a crucial feature. While healthcare professionals are still in charge of making all medical choices. The AI system offers trustworthy educational content, responds to frequently asked patient queries, and helps with routine engagement activities. AI technology and medical knowledge work together to increase operational effectiveness without sacrificing the standard or security of patient care.

The launch of Orphia is indicative of the expanding use of digital technology in contemporary healthcare. AI-powered systems are being adopted by healthcare companies more frequently to boost clinical productivity, increase patient engagement, and improve workflow efficiency. Bausch + Lomb exemplifies how medical technology businesses are extending their capabilities beyond conventional medical equipment to serve more interconnected, technologically advanced healthcare ecosystems by venturing into intelligent digital healthcare solutions.

Impact on the Healthcare Industry   

According to Precedence Research, to increase operational effectiveness, lower administrative complexity, and improve patient experiences, healthcare organizations are investing more in digital health and artificial intelligence technologies. To improve communication, streamline clinical operations, and enable healthcare providers to provide more individualized and effective care, intelligent healthcare platforms are becoming indispensable.

By incorporating AI-powered patient education and workflow optimization into ophthalmology practices, Bausch + Lomb's Orphia launch is in line with this industry shift. These developments are expected to boost digital transformation in specialized care, hasten the adoption of intelligent healthcare platforms, and stimulate additional investments in AI-enabled clinical solutions that enhance patient outcomes, physician efficiency, and healthcare delivery.

Impact on the Digital Health Market

The global digital health market size is calculated at USD 420.08 billion in 2025 and is predicted to increase from USD 483.07 billion in 2026 to approximately USD 1,171.24 billion by 2035, expanding at a CAGR of 10.8% from 2026 to 2035.

According to Precedence Research, the digital health market is expanding rapidly. Artificial intelligence, cloud-based healthcare platforms, connected medical technology, and intelligent workflow management systems are becoming more and more popular among healthcare providers. Hospitals and specialist clinics are able to provide more individualized healthcare services, increase patient involvement, and improve operational efficiency thanks to these technologies. The use of AI-powered healthcare platforms in clinical settings is anticipated to be accelerated by increasing expenditure in digital transformation.

By integrating AI-driven patient education, intelligence automation, and digital workflow optimization inside ophthalmic clinics, Bausch + Lomb's launch of Orphia exemplifies this industry trend. The platform shows how digital health technologies may improve patient provider communication while lowering administrative burdens. By promoting the usage of integrated healthcare platforms and AI-enabled patient engagement solutions, these advancements are expected to bolster the worldwide digital health market.

Impact on the Artificial Intelligence in Healthcare Market

The global artificial intelligence (AI) in healthcare market size is valued at USD 36.96 billion in 2025 and is predicted to increase from USD 51.20 billion in 2026 to approximately USD 744.34 billion by 2035, expanding at a CAGR of 35.02% from 2026 to 2035.

According to Precedence Research, artificial intelligence is becoming a crucial part of contemporary healthcare as doctors use AI more frequently to enhance patient experiences, automate repetitive administrative activities, and support clinical decision-making. To increase operational productivity and healthcare efficiency, healthcare companies are investing in sophisticated software solutions that allow doctors to spend more time providing high-quality treatment.

By incorporating conversational AI into clinical operations and patient education, Orphia mirrors the increasing use of AI in healthcare. The platform illustrates the growing significance of AI in specialty care by assisting patients in understanding treatment options and providing intelligent automation to support healthcare personnel. Similar developments are expected to boost workflow efficiency, hasten the implementation of AI in healthcare companies, and propel further expansion of the global market for AI in healthcare.

Impact on the Ophthalmology Market

The global ophthalmology market size is valued at USD 81.72 billion in 2025 and is predicted to increase from USD 86.71 billion in 2026 to approximately USD 152.86 billion by 2035, growing at a CAGR of 6.46% from 2026 to 2035.

According to Precedence Research, the ophthalmology market is improving treatment outcomes and healthcare accessibility through the growing use of digital technologies, sophisticated diagnostics, and patient-centered care models. To increase patient education, streamline clinical processes, and raise the standard of ophthalmic services, overall eye care physicians are increasingly utilizing cutting-edge technologies. Investments in cutting-edge ophthalmic technologies and digital healthcare solutions are also being encouraged by the increasing incidence of age-related eye illnesses and the growing need for minimally invasive eye therapies.

Orphia an AI powered platform created especially for ophthalmology practices was introduced by Bausch+Lomb to help this transition. The platform is expected to promote more digitalization throughout eye care services through increased clinical efficiency, simpler pre-surgical education, and improved patient engagement. Similar solutions are anticipated to increase patient happiness and spur innovation in the global ophthalmology market as ophthalmology clinics continue to implement sophisticated healthcare technologies. It is also expected that integrating AI with ophthalmic care will improve treatment planning, increase communication between doctors and patients, and enhance overall healthcare results in eye care practices across the globe.

About Bausch+Lomb

Bausch & Lomb is a multinational firm that specializes in consumer eye care solutions, medications, surgical instruments, and vision care products. The company, which operates in over 100 countries, concentrates on creating cutting-edge solutions that improve clinical outcomes and eye health. By combining artificial intelligence with ophthalmology to help medical professionals enhance patient interaction and further the digital revolution of eye care, Bausch + Lomb is growing its footprint in the field of digital healthcare with the introduction of Orphia.

The business keeps making investments in cutting-edge medical technology to enhance its current line of ophthalmic goods and services. Bausch + Lomb hopes to increase healthcare efficiency, improve patient-provider communication, and create more connected, individualized eye care experiences that meet the changing demands of contemporary healthcare systems by fusing clinical expertise with AI-powered digital solutions. The company's dedication to revolutionizing ophthalmic care through intelligent technologies that enhance clinical performance and patient outcomes is demonstrated by its ongoing investments in digital innovation. Bausch+  Lomb is establishing itself as a pioneer in the upcoming generation of digitally connected eye care services by brancing out from conventional medical items into AI eenabled healthcare platforms.